AXOXY Laboratories pioneers proteinaceous drug design and development
We present the poster "Advancing SODA to the Clinic" for Gator100 on Friday, February 19th, 2016, 9:30-11:30 in the lobby of the Hough Graduate School of Business at UF.
- Granted: "Mutant human superoxide dismutase 1 variants" (owned by the University of Florida Research Foundation but fully licensed to AXOXY) originally filed June 2010 issued December 2014 as U.S. Patent No. 8,916,373 B2 [pdf].
- "Monoatomic point mutant artificial oxidoreductases" originally filed June 2012 published December 2014 as U.S. Patent Application No. 13/924,451 [pdf].
ATG Bioinformatics (Mobile Applications)